Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Shi Zuo

4PUBLICATIONS
1CO-AUTHORS
Molecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

Sort by Publication Date:
|May 15, 2026
Targeting mitochondrial calcium homeostasis via novel S100A9 inhibitor B2 as a promising agent against AML.

|Mar 28, 2024
NAP1L1 regulates BIRC2 ubiquitination modification via E3 ubiquitin ligase UBR4 and hence determines hepatocellular carcinoma progression.

Shi-Long Zhang, Shen-Jie Zhang, Lian Li

|Feb 11, 2023
Immune landscape and immunotherapy of hepatocellular carcinoma: focus on innate and adaptive immune cells.

Xiaoqiang Gao, Shi Zuo

|Feb 08, 2022
Identification of MAD2L1 as a Potential Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis.

Qian Chen, Sibo Yang, Yewei Zhang

Pageof 1

Frequent Collaborators

1 joint publications

Teng-Xiang Chen

Frequent Collaborators

1 joint publications

Teng-Xiang Chen